Team IO+ selects and features the most important news stories on innovation and technology, carefully curated by our editors.
Montreal-based MoCA Cognition, a leader in cognitive health technology, is making its first foray into Europe by establishing an innovation hub in the Netherlands. There, it will advance its world-renowned digital assessment tools for neurodegenerative diseases. The company is known for its MoCA Test, an advanced diagnostic test that detects cognitive diseases like Alzheimer’s disease, Parkinson’s disease, brain tumors, and more.
Located at High Tech Campus Eindhoven, MoCA Cognition’s innovation hub aims to leverage the Netherlands’ innovative life sciences & health and tech ecosystems, skilled workforce, and R&D infrastructure. s in the global digital health market.
“This expansion to the Netherlands aligns with MoCA Cognition’s long-term growth strategy,” said Murray Gillies, PhD, Vice President of Science & Innovation at MoCA Cognition. “The new hub will accelerate the creation of AI-driven cognitive assessment products, ensuring the company stays at the forefront of cognitive health technology. This European presence provides the infrastructure to adapt to global market trends and maintain a competitive edge in the fast-evolving digital health sector.”
Leveraging Dutch expertise in AI
MoCA Cognition’s presence at High Tech Campus Eindhoven will enable the company to collaborate with key technology partners and leading knowledge institutions like Eindhoven University of Technology, which has vast expertise in AI and cognitive technologies. MoCA Cognition aims to harness the region’s deep talent pool in AI, machine learning, data science, and software development, all crucial for advancing its digital cognitive health tools.
MoCA Cognition finds that the Netherlands’ regulatory environment is conducive to R&D and innovation. The country offers various incentives for R&D activities, supporting MoCA Cognition’s development of AI-driven cognitive assessment tools. Additionally, the Netherlands has a robust data privacy framework, ensuring that the company’s digital health products adhere to European privacy regulations, such as the EU General Data Protection Regulation (GDPR). This further aligns with MoCA Cognition’s commitment to ethical and compliant technology development.
The Canadian company recognizes the Netherlands as a key gateway to the European market. The country’s central location and excellent infrastructure will provide MoCA Cognition with a strong base for future growth in other European countries. Its new subsidiary will not only serve as an R&D hub but also facilitate business development and partnership opportunities within the European Union. The Dutch ecosystem allows MoCA Cognition to meet the evolving needs of the global market, securing a competitive advantage in the rapidly growing field of digital health technologies. MoCA Cognition drew support from the Netherlands Foreign Investment Agency and Invest in Holland (partner of Brabant Development Agency) to smoothly transition into the Dutch innovation ecosystem.